Modafinil for the treatment of fatigue in lung cancer: A pilot study

Palliative Medicine

Volumn 23, Issue 4, 2009, Pages 325-331

  Spathis, A ^a,e   Dhillan, R ^b   Booden, D ^b   Forbes, K ^c   Vrotsou, K ^d   Fife, K ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b PETERBOROUGH DISTRICT HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Cancer; Central nervous system stimulant; Fatigue; Lung cancer; Modafinil

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID; MODAFINIL;

ADULT; AGED; ANXIETY; ARTICLE; CANCER FATIGUE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DEPRESSION; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEASIBILITY STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; NAUSEA; OPEN STUDY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

AGED; AGED, 80 AND OVER; BENZHYDRYL COMPOUNDS; CARCINOMA, NON-SMALL-CELL LUNG; CENTRAL NERVOUS SYSTEM STIMULANTS; FATIGUE; FEASIBILITY STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 65949103861     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269216309102614     Document Type: Article

References (38)

1. Vogelzang N Breitbart W Cella D Curt GA Groopman JE Horning SJ. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tri-part assessment survey. Semin Hematol 1997; 34 (Suppl. 2): 4-12.
2. Ashbury FD, Findlay H, Reynolds B, McKerracher K. A Canadian survey of cancer patient experiences; are their needs being met ? J Pain Symptom Manage 1998; 16: 298-306.
3. Tierney AJ, Leonard RC, Taylor J, Closs SJ, Chetty U, Rodger A. Side-effects expected and experienced by women receiving chemotherapy for breast cancer. Br Med J 1991; 302: 272.
4. Curt GA, Breitbart W, Cella D, Groopman JE, Horning SJ, Itri LM. Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition. Oncologist 2000;5: 353-360.
5. Curt GA. Fatigue in cancer. BMJ 2001; 322: 1560.
6. Mock V, Pickett M, Ropka M, Muscari Lin E, Stewart KJ, Rhodes VA. Fatigue and quality of life outcomes of exercise during cancer treatment. Cancer Pract 2001; 9: 19-27.
7. Dimeo FC, Stieglitz RD, Novelli-Fiscer U, Fetscher S, Keul J. Effects of physical activity on the fatigue and psychological status of cancer patients during chemotherapy. Cancer 1999; 85: 2273-2277.
8. Downer S, Joel S, Allbright A, Plant H, Stubbs L, Talbot D. A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia. Br J Cancer 1993; 67: 1102-1105.
9. Bruera E, Ernst S, Hagen N, Spachynski K, Belzile M, Hanson J. Effectiveness of megestrol acetate in patients with advanced cancer: A double-blind, crossover study. Cancer Prev Control 1998; 2: 74-78.
10. Breitbart W, Rosenfeld B, Kaim M, Fundesti-Esch J. A randomised, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease. Arch Intern Med 2001; 161: 411-420.
11. Weinshenker BG, Penman M, Bass B, Ebers GC, Rice GP. A double-blind, randomised, crossover trial of pemoline in fatigue associated with multiple sclerosis. Neurology 1992;42: 1468-1471.
12. Scammell TE, Estabrooke IV, McCarthy MT, Chemelli RM, Yanagisawa M, Miller MS. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 2000;20: 8620-8628.
13. Engber TM, Koury EJ, Dennis SA, Miller MS, Contreras PC, Bhat RV. Differential patterns of regional c-fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil. Neurosci Lett 1998; 241: 95-98.
14. Buguet A, Montmayeur A, Pigeau R, Naitoh P. Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. Effects on two nights of recovery sleep. Sleep Res 1995; 4: 229-241.
15. Batejat DM, Lagarde DP. Naps and modafinil as countermeasure for the effects of sleep deprivation on cognitive performance. Aviat Space Environ Med 1999; 70: 493-498.
16. Jasinski DR. An evaluation of the abuse potential of modafinil using methylphenidate as a reference. J Psychopharmacol 2000; 14: 53-60.
17. Data on file. Cephalon Study C1538a/303/AP/US/UK. Clinical study report.
18. Data on file. Cephalon UK Ltd. Written summary of clinical safety information; Provigil MAA, 2002.
19. Anonymous. Randomised trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicentre Study Group. Neurology 2000; 54: 1166-1175.
20. Caldwell JA, Caldwell JL, Smythe NK, Hall KK. A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: A helicopter simulator study. Psychopharmacology 2000; 150: 272-282.
21. Caldwell JA, Caldwell JL, Smith JK, Brown DL. Modafinil's effects on simulator performance and mood in pilots during 37 hours without sleep. Aviat Space Environ Med 2004; 75: 777-784.
22. Pigeau R, Naitoh P, Buguet A, McCann C, Baranski J, Taylor M. Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. Effects on mood, fatigue, cognitive performance and body temperature. J Sleep Res 1995; 4: 212-218.
23. Baranski JV, Pigeau R, Dinich P, Jacobs I. Effects of modafinil on cognitive and meta-cognitive performance. Hum Psychopharmacol 2004; 19: 323-332.
24. Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN. Efficacy and safety of modafinil for the treatment of fatigue in multiple sclerosis; a two centre phase 2 study. J Neurol Neurosurg Psychiatry 2002; 72: 179-183.
25. Zifko U, Rupp M, Schwarz S, Zipko HT, Maida E. Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study. J Neurol 2002; 249: 983-987.
26. Cox JM, Pappagallo M. Modafinil: A gift to portmanteau. Am J Hosp Palliat Care 2001; 18: 408-410.
27. Prommer, E. Modafinil: Is it ready for prime time ? J Opioid Manage 2006; 2: 130-136.
28. National Comprehensive Cancer Network. Cancer-related fatigue. Clinical practice guidelines in oncology. Version 1, 2009. http://www.nccn.org/ professionals/physician_gls/PDF/fatigue.pdf
29. Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D. Development of a fatigue scale. J Psychosom Res 1993; 37: 763-766.
30. Yellen S, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anaemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 1997; 13: 63-74.
31. Johns MW. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep 1992; 15: 376-381.
32. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370.
33. Cella D, Eton DT, Lei J, Peterman A, Merkel D. Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anaemia and fatigue subscales. J Pain Symptom Manage 2002; 24: 547-561.
34. Morrow G, Gillies L, Hickok J, Roscoe JA, Padmanaban D, Griggs JJ. The positive effect of the psychostimulant modafinil on fatigue from cancer that persists after treatment is completed. J Clin Oncol 2005; 23 (16S): 8012.
35. Stone P, Richards M, A'Hern R, Hardy J. A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol 2000; 11: 561-567.
36. Pater JL., Zee B, Palmer M, Johnston D, Osoba D. Fatigue in patients with cancer: Results with National Cancer Institute of Canada Clinical Trials Group studies employing EORTC QLQ-C30. Support Care Cancer 1997; 5: 410-413.
37. National Cancer Research Institute. Lung cancer research in the UK: report of the NCRI Strategic Planning Group on Lung Cancer, London: NCRI, 2006.
38. Stankoff B Waubant E Confavreux C Edan G Debouverie M Rumbach L. Modafinil for fatigue in MS: A randomised placebo-controlled double-blind study. Neurology 2005; 64: 1139- 1143.